The activation of GPER1 can inhibit the phosphorylation of IKBKB/IKK-β and IKB, which rapidly decreases the phosphorylation, nuclear translocation, and activity of NF-κB in human NSCLC cells [27]. Here, NFKB1 is linked to non-small cell lung carcinoma.